JFG
INO icon

Jefferies Financial Group’s Inovio Pharmaceuticals INO Stock Holding History

Jefferies Financial Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,500
Closed -$160K – 1616
2024
Q1 		$160K Buy
+11,500
New +$99.3K ﹤0.01% 1378

Other funds holding INO

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jefferies Financial Group's INO Position: Q2 2024 in Review

Jefferies Financial Group sold out of Inovio Pharmaceuticals (INO) in Q2 2024, closing a stake of 11,500 shares — an estimated $160K sold.

Jefferies Financial Group first reported a position in INO in Q1 2024 and held it in 1 quarter. The position peaked at $160K in Q1 2024. 96 funds tracked by Wall St. Rank hold INO as of Q2 2024.

  • Jefferies Financial Group reported no remaining Inovio Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 11,500 Inovio Pharmaceuticals shares in Q2 2024, an estimated $160K.
  • Jefferies Financial Group first reported a position in Inovio Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Jefferies Financial Group's Inovio Pharmaceuticals position peaked at $160K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.